Dr. Lal PathLabs Limited (LALPATHLAB)

Name: Dr. Lal PathLabs Limited (LALPATHLAB) — historial de estados financieros
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.

Healthcare · Wall Street (EE. UU.) · Última actualización: 2026-09-20

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.

Cifras clave

Capitalización bursátil: ₹317 billion
Ingresos (ejercicio cerrado en 2026-03-31): ₹27.6B
Beneficio neto: ₹5.0B
Margen bruto: 80.6%
Margen neto: 18.3%

Ver gráficos interactivos y estados completos →

Cuenta de resultados anual

Cuenta de resultados	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Ingresos totales	₹27.6B	₹24.6B	₹22.3B	₹20.2B
Beneficio bruto	₹22.3B	₹19.8B	₹14.6B	₹12.9B
Ingresos operativos (EBIT)	₹10.2B	₹9.0B	₹4.7B	₹3.4B
Ingresos netos	₹5.0B	₹4.9B	₹3.6B	₹2.4B

Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.

Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de LALPATHLAB. /companies/us/LALPATHLAB

Empresas similares

La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.

English version →Todas las acciones

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.